Status:
COMPLETED
A Study Investigating the Efficacy of GON Blocks.
Lead Sponsor:
Barts & The London NHS Trust
Conditions:
Migraine
Chronic Migraine, Headache
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Greater occipital nerve block ("GON block") is carried out extensively in the treatment of chronic migraine, but more research is required to understand the effectiveness of the procedure. It consists...
Detailed Description
Chronic migraine is characterised by frequency of headache ≥ 15 days per month for more than 3 months. The location can be unilateral or bilateral. Usually described as pulsating in nature, it may be ...
Eligibility Criteria
Inclusion
- Patients aged over the age of 18 who are able to provide a written consent
- Ability to read and write English, due to questionnaire use in study
- Diagnosis of chronic migraine with or without acute relief medication overuse (ICHD-III codes 1.3 and 8.2); as confirmed by diary documentation (headache on 15 or more days a month for at least 3 months)
Exclusion
- Patient refusal
- Participation in any trial of any investigational products or interventional research project within the previous eight weeks to enrolment
- Patients unable to commit to the six-month study duration (PI judgment)
- Any known contraindication(s) to the IMPs as described by the manufacturer's Summary of Product Characteristics (SmPCs)
- Patients with a history of substance abuse
- Pregnant or breastfeeding patients
Key Trial Info
Start Date :
February 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04017741
Start Date
February 14 2018
End Date
January 23 2020
Last Update
March 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom, EC1A 4NP